This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In addition, MDisrupt will add new features to the marketplace platform through a strategic collaboration with the Association to meet the needs of its members, providing new ways for them to engage with the health technology, health services, medical device, and lifesciences sectors.
–(BUSINESS WIRE)– #Biotech –Taking a people-first approach, BioscienceLA, the ecosystem accelerator for lifesciences in Greater Los Angeles, has launched its inaugural Leadership Catalyst Program for trailblazers in biotechnology and related sectors. We are delighted to be part of this impactful program.”
Biotech Showcase is true to its name – great companies are highlighted.” Tina Elder, Global Managing Director, EBD Group US, said, “Biotech Showcase has once again shown itself to be the premiere destination for innovators and partners to access a powerful network of industry decision-makers, media and top investors.
As we kick off 2024, we wanted to start the new year with a series of 2024 Health IT predictions. There is a growing interest in the integration of safety services with technology, and this will continue into 2024. In fact, we got so many that we had to narrow them down to just the best and most interesting.
The round was led by Eventide Asset Management (Eventide), which invests in biotech and lifescience healthcare companies seeking solutions for unmet clinical needs. Originally announced August 21st, 2024 million in Series B funding, bringing its total funding to date to $31.5
This new fund underscores the firm’s continued commitment to driving innovation and elevating health globally through investments in digital health, medical devices, lifesciences, and tech-enabled care delivery. OpenLoop : An end-to-end telemedicine enablement company surpassed $100 million in annualized revenues in early 2024.
Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients. Petra Jantzer, Ph.D.,
EVERSANA INTOUCH Healthware joins five full-service affiliates and four specialty affiliates serving clients across the globe with world-class strategy, next-generation branding and creative, and innovative solutions to propel the future of lifescience marketing. They are, however, fully owned and operated by EVERSANA.
The JP Morgan 42nd Annual Healthcare Conference will take place January 8-11, 2024 in San Francisco, CA, USA. Francis Hotel is invite-only, but thousands of professionals from the healthcare and lifesciences sector make the journey to San Francisco to participate in the adjacent events. Who attends?
” Google Cloud released new capabilities in Vertex AI Search for healthcare and lifesciences, highlighting Hackensack Meridian Health and Highmark Health in its announcement. RedHealthy Communications : PR and marketing for biotech, lifesciences, and digital health.
The facility’s location will further EIT’s current partnerships in the Oxford biotech and technology communities, expand collaborations with the University of Oxford, and support the new Ellison Scholars programme. Prof Bell will also become Co-CEO of EIT Global, alongside Dr David Agus.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content